Labocanna

Labocanna Net Debt/FCF

Net Debt to Free Cash Flow Ratio of Labocanna (LCN.WA) as of Oct 18, 2026.

Net Debt/FCF

-0.00

YoY

-101.06%

Last updated:

Net Debt to Free Cash Flow Ratio of Labocanna is 2022 -0.00 . Net Debt to Free Cash Flow Ratio of Labocanna was 2021 0.29 . It decreases by -101.06% lower compared to the previous year.

The Labocanna Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2015
4.64 PLN
Jan 1, 2016
-6.11 PLN
Jan 1, 2017
-0.50 PLN
Jan 1, 2018
-1.58 PLN
Jan 1, 2019
19.33 PLN
Jan 1, 2021
0.29 PLN
Jan 1, 2022
-0.00 PLN
The Labocanna Net Debt/FCF history
YEARNet Debt/FCFYoY
-0.00-101.06%
0.29-98.51%
19.33-1,324.44%
-1.58+218.83%
-0.50-91.90%
-6.11-231.81%
4.64—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Labocanna since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Labocanna with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Labocanna

All Key Metrics — Labocanna